Publication | Closed Access
24 Phase III study of gemcitabine (Gemzar®) versus best supportive care (BSC) in advanced non-small cell lung cancer (NSCLC)
24
Citations
0
References
1997
Year
MedicineCancer ManagementPhase Iii StudyCancer TreatmentOncologyRadiation OncologyLung Cancer
No additional data available for this publication yet. Check back later!